Crome/Cobalt Respiration Study

N/A Completed NCT06089694

Condition	Heart Failure
Phase	N/A
Sponsor	Medtronic Cardiac Rhythm and Heart Failure
Status	Completed
Enrollment	61 participants
Interventions	Enabling Sensor Research Holter Mode feature
Start date	Nov 21, 2023
Completion date	Jun 12, 2024
Results posted	Jul 21, 2026

Summary

The goal of this study is to compare measured respiration rates in various subject scenarios and use conditions between capnography and the Crome and Cobalt ICD and CRT-D MRI SureScan devices (derived using a Holter recorder).

Daily Capnography Respiration Rate

During In-clinic Testing Visit, an average of 2 hours · breaths per minute

All Enrolled Subjects	15.3 ± 3.7 breaths per minute

Daily Device-derived Respiration Rate

During In-clinic Testing Visit, an average of 2 hours · breaths per minute

All Enrolled Subjects	15.5 ± 3.5 breaths per minute

Difference in Respiration Rate

During In-clinic Testing Visit, an average of 2 hours · breaths per minute

All Enrolled Subjects	0.2 ± 1.1 breaths per minute

Open in BENITIONS View on ClinicalTrials.gov

Other trials for this condition

Implantation of a Permanent Interatrial Shunt to Reduce Left Atrial Filling Pressures Foll — samir kapadia
Precision Guided Tacrolimus Dosing in Pediatric Heart Transplant — University of Utah
Mechanism and Effects of Manipulating Chloride Homeostasis in Acute Heart Failure — Yale University
Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using th — Boston Children's Hospital
PROACTIVE-HF IDE Trial Heart Failure NYHA Class III — Endotronix, Inc.
Improving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care Coord — Weill Medical College of Cornell University

All trials

This page summarises publicly available data from ClinicalTrials.gov. It is not medical advice and not investment advice. Always consult a qualified healthcare professional.

English 한국어 日本語中文 Русский